9006 ORAL Results of a Phase 2 Study of Gemcitabine/Cisplatin/lniparib (GCI) Versus Gemcitabine/cisplatin (GC) in Patients With Advanced NSCLC

S. Novello, E. Felip, F. Barlesi, J. Mazieres, G. Zalcman, J. von Pawel, M. Reck, F. Cappuzzo, D. Ferry, J.C. Soria
  • European Journal of Cancer, September 2011, Elsevier
  • DOI: 10.1016/s0959-8049(11)72318-8

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo